José R Romero1, Sarah R Preis2, Alexa Beiser2, Jayandra J Himali2, Ashkan Shoamanesh2, Philip A Wolf2, Carlos S Kase2, Ramachandran S Vasan2, Charles DeCarli2, Sudha Seshadri2. 1. From the Department of Neurology (J.R.R., A.B., P.A.W., C.S.K., S.S.), Section of Preventive Medicine (V.S.R.), and Department of Cardiology (V.S.R.), School of Medicine and Department of Biostatistics (S.R.P., A.B., J.J.H.), School of Public Health at Boston University, MA; Department of Medicine-Neurology, McMaster University and Population Health Research Institute, Hamilton, Ontario, Canada (A.S.); Department of Neurology, University of California-Davis (C.D.); and the NHLBI's Framingham Heart Study, Framingham, MA (J.R.R., S.R.P., A.B., J.J.H., P.A.W., C.S.K., V.S.R., S.S.). joromero@bmc.org. 2. From the Department of Neurology (J.R.R., A.B., P.A.W., C.S.K., S.S.), Section of Preventive Medicine (V.S.R.), and Department of Cardiology (V.S.R.), School of Medicine and Department of Biostatistics (S.R.P., A.B., J.J.H.), School of Public Health at Boston University, MA; Department of Medicine-Neurology, McMaster University and Population Health Research Institute, Hamilton, Ontario, Canada (A.S.); Department of Neurology, University of California-Davis (C.D.); and the NHLBI's Framingham Heart Study, Framingham, MA (J.R.R., S.R.P., A.B., J.J.H., P.A.W., C.S.K., V.S.R., S.S.).
Abstract
BACKGROUND AND PURPOSE: Cerebral microbleeds (CMB) represent a common magnetic resonance imaging marker of cerebral small vessel disease, increasingly recognized as a subclinical marker of stroke and dementia risk. CMB detection may reflect the cumulative effect of vascular risk burden and be a marker of higher mortality. We investigated the relation of CMB to risk of death in community dwelling participants free of stroke and dementia. METHODS: We evaluated 1963 Framingham Original and Offspring Cohort participants (mean age 67 years; 54% women) with available brain magnetic resonance imaging and mortality data. Using Cox proportional hazards models, we related CMB to all-cause, cardiovascular, and stroke-related mortality. RESULTS: Participants with CMB (8.9%) had higher prevalence of cardiovascular risk factors and use of preventive medications. During a mean follow-up of 7.2±2.6 years, we observed 296 deaths. In age- and sex-adjusted analysis, CMB were associated with increased all-cause mortality (hazards ratio, 1.39; 95% confidence interval 1.03-1.88), a relation that was no longer significant after adjustment for cardiovascular risk and preventive medication use (hazards ratio, 1.15; 95% confidence interval, 0.82-1.63). CONCLUSIONS: CMBs may represent the deleterious effect of cardiovascular risk factors in the cerebral vasculature. Although their presence was associated with increased all-cause mortality, the effect was no longer present after accounting for vascular risk factors and preventive treatment use. Further studies are required to clarify the role of cardiovascular preventive therapies for prevention of mortality in persons with incidental detection of CMB.
BACKGROUND AND PURPOSE: Cerebral microbleeds (CMB) represent a common magnetic resonance imaging marker of cerebral small vessel disease, increasingly recognized as a subclinical marker of stroke and dementia risk. CMB detection may reflect the cumulative effect of vascular risk burden and be a marker of higher mortality. We investigated the relation of CMB to risk of death in community dwelling participants free of stroke and dementia. METHODS: We evaluated 1963 Framingham Original and Offspring Cohort participants (mean age 67 years; 54% women) with available brain magnetic resonance imaging and mortality data. Using Cox proportional hazards models, we related CMB to all-cause, cardiovascular, and stroke-related mortality. RESULTS:Participants with CMB (8.9%) had higher prevalence of cardiovascular risk factors and use of preventive medications. During a mean follow-up of 7.2±2.6 years, we observed 296 deaths. In age- and sex-adjusted analysis, CMB were associated with increased all-cause mortality (hazards ratio, 1.39; 95% confidence interval 1.03-1.88), a relation that was no longer significant after adjustment for cardiovascular risk and preventive medication use (hazards ratio, 1.15; 95% confidence interval, 0.82-1.63). CONCLUSIONS:CMBs may represent the deleterious effect of cardiovascular risk factors in the cerebral vasculature. Although their presence was associated with increased all-cause mortality, the effect was no longer present after accounting for vascular risk factors and preventive treatment use. Further studies are required to clarify the role of cardiovascular preventive therapies for prevention of mortality in persons with incidental detection of CMB.
Authors: Irmhild Altmann-Schneider; Stella Trompet; Anton J M de Craen; Adriaan C G M van Es; J Wouter Jukema; David J Stott; Naveed Sattar; Rudi G J Westendorp; Mark A van Buchem; Jeroen van der Grond Journal: Stroke Date: 2011-01-13 Impact factor: 7.914
Authors: José Rafael Romero; Sarah R Preis; Alexa Beiser; Charles DeCarli; Anand Viswanathan; Sergi Martinez-Ramirez; Carlos S Kase; Philip A Wolf; Sudha Seshadri Journal: Stroke Date: 2014-04-08 Impact factor: 7.914
Authors: Saloua Akoudad; Mohammad Arfan Ikram; Peter Jan Koudstaal; Albert Hofman; Aad van der Lugt; Meike Willemijn Vernooij Journal: Eur J Epidemiol Date: 2013-09-26 Impact factor: 8.082
Authors: Marije R Benedictus; Niels D Prins; Jeroen D C Goos; Philip Scheltens; Frederik Barkhof; Wiesje M van der Flier Journal: JAMA Neurol Date: 2015-05 Impact factor: 18.302
Authors: Jacqueline A Pettersen; Gayathri Sathiyamoorthy; Fu-Qiang Gao; Gregory Szilagyi; Neelesh K Nadkarni; Peter St George-Hyslop; Ekaterina Rogaeva; Sandra E Black Journal: Arch Neurol Date: 2008-06
Authors: Steven M Greenberg; Meike W Vernooij; Charlotte Cordonnier; Anand Viswanathan; Rustam Al-Shahi Salman; Steven Warach; Lenore J Launer; Mark A Van Buchem; Monique Mb Breteler Journal: Lancet Neurol Date: 2009-02 Impact factor: 44.182
Authors: Panteleimon Giannakopoulos; Marie-Louise Montandon; François R Herrmann; Dennis Hedderich; Christian Gaser; Elias Kellner; Cristelle Rodriguez; Sven Haller Journal: Eur Radiol Date: 2022-04-29 Impact factor: 5.315
Authors: Andreas Charidimou; Sara Shams; Jose R Romero; Jie Ding; Roland Veltkamp; Solveig Horstmann; Gudny Eiriksdottir; Mark A van Buchem; Vilmundur Gudnason; Jayandra J Himali; M Edip Gurol; Anand Viswanathan; Toshio Imaizumi; Meike W Vernooij; Sudha Seshadri; Steven M Greenberg; Oscar R Benavente; Lenore J Launer; Ashkan Shoamanesh Journal: Int J Stroke Date: 2018-01-17 Impact factor: 5.266
Authors: Ashkan Shoamanesh; Andrea Morotti; Javier M Romero; Jamary Oliveira-Filho; Frieder Schlunk; Michael J Jessel; Alison M Ayres; Anastasia Vashkevich; Kristin Schwab; Mohammad R Afzal; Christy Cassarly; Renee H Martin; Adnan I Qureshi; Steven M Greenberg; Jonathan Rosand; Joshua N Goldstein Journal: JAMA Neurol Date: 2018-07-01 Impact factor: 18.302